Pharma Continues Its March To Academia, as Sanofi, UCB Strike Deals
This article was originally published in The Pink Sheet Daily
Executive Summary
In two very different collaborations, Sanofi teams up with Weill Cornell professor to screen for TB drug candidates, while UCB initiates its first project under a strategic research alliance with Harvard.